Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Abivax (ABVX) Assets Average: 2022-2025

  • Abivax's Assets Average was N/A to $155.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $155.5 million, marking a year-over-year change of. This contributed to the annual value of $285.6 million for FY2024, which is 32.37% up from last year.
  • Per Abivax's latest filing, its Assets Average stood at $155.5 million for Q2 2025, which was down 21.24% from $197.5 million recorded in Q1 2025.
  • In the past 5 years, Abivax's Assets Average registered a high of $262.8 million during Q4 2024, and its lowest value of $101.0 million during Q4 2022.
  • Its 3-year average for Assets Average is $207.6 million, with a median of $206.0 million in 2023.
  • Data for Abivax's Assets Average shows a peak YoY spiked of 112.33% (in 2023) over the last 5 years.
  • Abivax's Assets Average (Quarterly) stood at $101.0 million in 2022, then surged by 112.33% to $214.5 million in 2023, then grew by 22.54% to $262.8 million in 2024, then reached $155.5 million in 2025.
  • Its Assets Average was $155.5 million in Q2 2025, compared to $197.5 million in Q1 2025 and $262.8 million in Q4 2024.